The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry

In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome 17 abnormalities has not yet been fully elucidated, except for isochromosome 17q that has been characterized as an intermediate risk abnormality in the Revised International Prognostic Scoring System (IPSS‐R)....

詳細記述

保存先:
書誌詳細
出版年:Cancer Med
主要な著者: Diamantopoulos, Panagiotis, Koumbi, Dafni, Kotsianidis, Ioannis, Pappa, Vasiliki, Symeonidis, Argiris, Galanopoulos, Athanasios, Zikos, Panagiotis, Papadaki, Helen A., Panayiotidis, Panayiotis, Dimou, Maria, Hatzimichael, Eleftheria, Vassilopoulos, George, Delimpasis, Susan, Mparmparousi, Despoina, Papageorgiou, Sotirios, Variami, Eleni, Kyrtsonis, Marie‐Christine, Megalakaki, Aekaterini, Kotsopoulou, Maria, Repousis, Panagiotis, Adamopoulos, Ioannis, Kontopidou, Flora, Christoulas, Dimitrios, Kourakli, Alexandra, Tsokanas, Dimitrios, Konstantinos Papoutselis, Menelaos, Kyriakakis, Georgios, Viniou, Nora‐Athina
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2019
主題:
Clinical Cancer Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536924/
https://ncbi.nlm.nih.gov/pubmed/30897290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2090
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料